{"id":2379,"date":"2013-12-19T12:54:26","date_gmt":"2013-12-19T12:54:26","guid":{"rendered":"https:\/\/medicalcriteria.com\/web\/ccsg\/"},"modified":"2025-05-13T20:27:48","modified_gmt":"2025-05-13T20:27:48","slug":"ccsg","status":"publish","type":"post","link":"https:\/\/medicalcriteria.com\/web\/es\/ccsg\/","title":{"rendered":"Gu\u00eda para el Screening de C\u00e1ncer Cervical"},"content":{"rendered":"<div class=\"7ca9444b8380138fe077da07353677a4\" data-index=\"1\" style=\"float: none; margin:0px 0 0px 0; text-align:center;\">\n<script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js\"><\/script>\r\n<!-- MC 2019- Horizontal -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-0127150553352455\"\r\n     data-ad-slot=\"3806776041\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script>\n<\/div>\n<p>La incidencia de c\u00e1ncer de cuello uterino, as\u00ed como la tasa de mortalidad de la enfermedad, ha disminuido en los \u00faltimos 30 a\u00f1os debido al screening generalizado con citolog\u00eda cervical. El Colegio Americano de Obstetras y Ginec\u00f3logos (ACOG) ha publicado recientemente una gu\u00eda de manejo cl\u00ednico sobre el cribado de citolog\u00eda cervical.<br \/>\n<!--more--><br \/>\n<strong>Gu\u00eda para el Screening de C\u00e1ncer Cervical<\/strong><strong>*<\/strong><\/p>\n<table style=\"width: 100%;\" border=\"1\" width=\"100%\" cellspacing=\"0\" cellpadding=\"4\">\n<colgroup>\n<col width=\"92*\" \/>\n<col width=\"164*\" \/><\/colgroup>\n<tbody>\n<tr valign=\"TOP\">\n<td style=\"width: 23.3939%;\" width=\"36%\"><strong>Grupo de edad<\/strong><\/td>\n<td style=\"width: 76.6061%;\" width=\"64%\"><strong>Recomendaci\u00f3n de Screening<\/strong><\/td>\n<\/tr>\n<tr valign=\"TOP\">\n<td style=\"width: 23.3939%;\" width=\"36%\">&lt; 21 a\u00f1os<\/td>\n<td style=\"width: 76.6061%;\" width=\"64%\">No realizar screen.<\/td>\n<\/tr>\n<tr valign=\"TOP\">\n<td style=\"width: 23.3939%;\" width=\"36%\">21-29 a\u00f1os<\/td>\n<td style=\"width: 76.6061%;\" width=\"64%\">Realizar pruebas citol\u00f3gicas solo cada 3 a\u00f1os.<\/td>\n<\/tr>\n<tr valign=\"TOP\">\n<td style=\"width: 23.3939%;\" width=\"36%\">30-65 a\u00f1os<\/td>\n<td style=\"width: 76.6061%;\" width=\"64%\">Realizar cotesteo citol\u00f3gico y VPH \u00a0cada 5 a\u00f1os (preferido), o realizar pruebas citol\u00f3gicas solo cada 3 a\u00f1os (aceptable).**<\/td>\n<\/tr>\n<tr valign=\"TOP\">\n<td style=\"width: 23.3939%;\" width=\"36%\">&gt; 65 a\u00f1os<\/td>\n<td style=\"width: 76.6061%;\" width=\"64%\">Discontinuar la detecci\u00f3n si ha habido un n\u00famero suficiente de resultados del cribado negativos previamente\u00a0(3 pruebas consecutivas negativas citol\u00f3gicas o 2 cotests negativos consecutivos en los \u00faltimos 10 a\u00f1os, con la prueba m\u00e1s reciente de los \u00faltimos 5 a\u00f1os) y si no hay una historia de HSIL ,*** adenocarcinoma in situ, o c\u00e1ncer.<\/td>\n<\/tr>\n<tr valign=\"TOP\">\n<td style=\"width: 23.3939%;\" width=\"36%\">Mujeres con histerectom\u00eda previa<\/td>\n<td style=\"width: 76.6061%;\" width=\"64%\">Cesar la detecci\u00f3n si el paciente se ha sometido a una histerectom\u00eda total con extirpaci\u00f3n de cuello uterino y si no hay historia de HSIL, adenocarcinoma in situ, o c\u00e1ncer.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>* Los tres principales conjuntos de pautas de detecci\u00f3n fueron emitidas por la American Cancer Society, American Society for Colposcopy and Cervical Pathology, y la American Society for Clinical Pathology Multisociety Guidelines Group , elAmerican College of Obstetricians and Gynecologists y la U.S. Preventive Services Task Force (USPSTF). Las gu\u00edas est\u00e1n de acuerdo en la mayor\u00eda de las recomendaciones, que incluyen la edad recomendada en el inicio de la detecci\u00f3n (21 a\u00f1os), la edad en que la detecci\u00f3n puede ser interrumpido si la historia de cribado negativo es adecuada (&gt; 65 a\u00f1os), y el intervalo recomendado entre las pruebas. Espec\u00edficamente, el cotesteo en un intervalo de 5 a\u00f1os es ya preferido o aceptable para las mujeres de 30 a 65 a\u00f1os de edad, mientras que la prueba citol\u00f3gica solo cada 3 a\u00f1os es aceptable para las mujeres 21 a 65 a\u00f1os de edad. HSIL denota lesi\u00f3n intraepitelial escamosa de grado alto.<br \/>\n** Los t\u00e9rminos \u00abpreferido\u00bb y \u00abaceptable\u00bb no est\u00e1n incluidos en la Declaraci\u00f3n de la Recomendaci\u00f3n USPSTF.<br \/>\n*** HSIL incluye neoplasia cervical intraepitelial grado 3 y los casos de grado 2 que ti\u00f1en positivo para p16.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Bibliograf\u00eda:<\/strong><\/p>\n<ol>\n<li>Schiffman M, Solomon D. Clinical practice. Cervical-cancer screening with human papillomavirus and cytologic cotesting. N Engl J Med. 2013 Dec 12;369(24):2324-31.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24328466\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<li>Tatsas AD, Phelan DF, Gravitt PE, Boitnott JK, Clark DP. Practice patterns in cervical cancer screening and human papillomavirus testing. Am J Clin Pathol. 2012 Aug;138(2):223-9.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22904133\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<li>Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22422631\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<li>Moyer VA. Screening for cervical cancer:\u00a0U.S. Preventive Services Task Force\u00a0recommendation statement. Ann Intern\u00a0Med 2012;156:880-91.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22711081\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<li>ACOG Practice Bulletin number 131:\u00a0screening for cervical cancer. Obstet Gynecol\u00a02012;120:1222-38.\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23090560\/\" target=\"_blank\" rel=\"noopener noreferrer\">[Medline]<\/a><\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p>Creado: 20 Ene, 2014<\/p>\n\n<div style=\"font-size: 0px; height: 0px; line-height: 0px; margin: 0; padding: 0; clear: both;\"><\/div>","protected":false},"excerpt":{"rendered":"<p>La incidencia de c\u00e1ncer de cuello uterino, as\u00ed como la tasa de mortalidad de la enfermedad, ha disminuido en los \u00faltimos 30 a\u00f1os debido al screening generalizado con citolog\u00eda cervical. El Colegio Americano de Obstetras y Ginec\u00f3logos (ACOG) ha publicado recientemente una gu\u00eda de manejo cl\u00ednico sobre el cribado de citolog\u00eda cervical.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"no","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[87],"tags":[1013,322,1012,1011,273,274,1010,1009,645],"class_list":["post-2379","post","type-post","status-publish","format-standard","hentry","category-obstetrics-gynecology","tag-american","tag-cancer","tag-cervical","tag-college","tag-guia","tag-guidelines","tag-gynecologists","tag-obstetricians","tag-screening"],"modified_by":"Guillermo Firman","_links":{"self":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/comments?post=2379"}],"version-history":[{"count":4,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2379\/revisions"}],"predecessor-version":[{"id":9386,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/posts\/2379\/revisions\/9386"}],"wp:attachment":[{"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/media?parent=2379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/categories?post=2379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalcriteria.com\/web\/es\/wp-json\/wp\/v2\/tags?post=2379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}